DK0456519T3 - Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse - Google Patents
Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelseInfo
- Publication number
- DK0456519T3 DK0456519T3 DK91304254.5T DK91304254T DK0456519T3 DK 0456519 T3 DK0456519 T3 DK 0456519T3 DK 91304254 T DK91304254 T DK 91304254T DK 0456519 T3 DK0456519 T3 DK 0456519T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- quinuclidinyloxyisoxazole
- piperidyloxy
- derivatives
- preparation
- Prior art date
Links
- TYKDAIZLVDFALU-UHFFFAOYSA-N 3-(1-azabicyclo[2.2.2]octan-2-yloxy)-1,2-oxazole Chemical class C1CN2CCC1CC2OC=1C=CON=1 TYKDAIZLVDFALU-UHFFFAOYSA-N 0.000 title 1
- -1 Piperidyloxy Chemical group 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005936 piperidyl group Chemical group 0.000 abstract 2
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000004970 halomethyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11975490 | 1990-05-11 | ||
| JP21651990 | 1990-08-17 | ||
| JP27848990 | 1990-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0456519T3 true DK0456519T3 (da) | 1994-11-07 |
Family
ID=27313898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91304254.5T DK0456519T3 (da) | 1990-05-11 | 1991-05-10 | Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5643923A (cs) |
| EP (1) | EP0456519B1 (cs) |
| JP (1) | JPH0747585B2 (cs) |
| KR (1) | KR0178369B1 (cs) |
| CN (1) | CN1042225C (cs) |
| AT (1) | ATE108448T1 (cs) |
| CA (1) | CA2042336A1 (cs) |
| CZ (1) | CZ284343B6 (cs) |
| DE (1) | DE69102816T2 (cs) |
| DK (1) | DK0456519T3 (cs) |
| ES (1) | ES2060303T3 (cs) |
| HK (1) | HK1005728A1 (cs) |
| HU (2) | HU215832B (cs) |
| IE (1) | IE65997B1 (cs) |
| PT (1) | PT97637B (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE124865T1 (de) * | 1986-12-17 | 1995-07-15 | Glaxo Group Ltd | Verwendung von heterocyclischen verbindungen zur behandlung von bewusstseinsstörungen. |
| EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
| GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
| DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
| US5821371A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Comany | Heterocyclic compounds and their preparation and use |
| US6040442A (en) * | 1995-06-01 | 2000-03-21 | Eli Lilly And Company | Process for preparing 1,2,5-thiadiazole containing ethers |
| KR19990087339A (ko) * | 1996-02-27 | 1999-12-27 | 가와무라 요시부미 | 이속사졸 유도체 |
| UA52698C2 (uk) | 1996-10-04 | 2003-01-15 | Х. Луннбек А/С | Похідні (3-алкоксіізоксазол-4-іл)заміщеної 2-амінокарбонової кислоти та їх сірковмісні аналоги, фармацевтична композиція на їх основі |
| ATE315033T1 (de) | 1998-08-07 | 2006-02-15 | Chiron Corp | Subtituierte isoxazole derivate als estrogen rezeptor modulatore |
| US7655657B2 (en) | 2003-12-22 | 2010-02-02 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US7160876B2 (en) | 2003-12-22 | 2007-01-09 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| AR079493A1 (es) | 2009-12-21 | 2012-02-01 | Nippon Soda Co | Compuesto de amina ciclica y acaricida |
| AR081721A1 (es) | 2010-02-25 | 2012-10-17 | Nippon Soda Co | Compuesto de amina ciclica y acaricida |
| HU230649B1 (hu) | 2013-01-24 | 2017-05-29 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Javított eljárás prasugrel gyógyszeripari hatóanyag és az 1-ciklopropil-2-(2-fluorofenil)-etanon intermedier előállítására |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3290301A (en) * | 1963-12-02 | 1966-12-06 | Shionogi & Co | Certain 3-aminoalkyl-5-alkylisoxazoles |
| AT254868B (de) * | 1964-02-13 | 1967-06-12 | Shionogi & Co | Verfahren zur Herstellung von neuen disubstituierten Isoxazolverbindungen |
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| US5321037A (en) * | 1986-12-26 | 1994-06-14 | Sankyo Company, Limited | Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants |
| ZA879631B (en) * | 1986-12-26 | 1989-08-30 | Sankyo Co | Centrally-acting muscle relaxants |
| CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
| CA1329128C (en) * | 1988-03-24 | 1994-05-03 | Nobuyoshi Iwata | Isoxazolinones as cerebro-active drugs |
| IE62276B1 (en) * | 1988-03-30 | 1995-01-25 | Sankyo Co | "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants" |
| US5116839A (en) * | 1989-06-26 | 1992-05-26 | Sankyo Company, Limited | Use of isoxazolin-3-one derivatives as antidepressants |
| YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
-
1991
- 1991-05-10 CZ CS911385A patent/CZ284343B6/cs not_active IP Right Cessation
- 1991-05-10 EP EP91304254A patent/EP0456519B1/en not_active Expired - Lifetime
- 1991-05-10 CA CA002042336A patent/CA2042336A1/en not_active Abandoned
- 1991-05-10 DK DK91304254.5T patent/DK0456519T3/da active
- 1991-05-10 HU HU1568/91A patent/HU215832B/hu not_active IP Right Cessation
- 1991-05-10 IE IE159891A patent/IE65997B1/en unknown
- 1991-05-10 AT AT91304254T patent/ATE108448T1/de not_active IP Right Cessation
- 1991-05-10 DE DE69102816T patent/DE69102816T2/de not_active Expired - Fee Related
- 1991-05-10 JP JP3105741A patent/JPH0747585B2/ja not_active Expired - Lifetime
- 1991-05-10 ES ES91304254T patent/ES2060303T3/es not_active Expired - Lifetime
- 1991-05-10 PT PT97637A patent/PT97637B/pt not_active IP Right Cessation
- 1991-05-11 KR KR1019910007621A patent/KR0178369B1/ko not_active Expired - Fee Related
- 1991-05-11 CN CN91103768A patent/CN1042225C/zh not_active Expired - Fee Related
-
1992
- 1992-08-27 US US07/937,445 patent/US5643923A/en not_active Expired - Fee Related
-
1995
- 1995-06-29 HU HU95P/P00539P patent/HU211875A9/hu unknown
-
1998
- 1998-06-03 HK HK98104828A patent/HK1005728A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US5643923A (en) | 1997-07-01 |
| CN1042225C (zh) | 1999-02-24 |
| IE911598A1 (en) | 1991-11-20 |
| CN1057259A (zh) | 1991-12-25 |
| HU211875A9 (en) | 1995-12-28 |
| ATE108448T1 (de) | 1994-07-15 |
| JPH0747585B2 (ja) | 1995-05-24 |
| JPH04225977A (ja) | 1992-08-14 |
| IE65997B1 (en) | 1995-11-29 |
| DE69102816T2 (de) | 1995-03-16 |
| PT97637A (pt) | 1992-02-28 |
| KR0178369B1 (ko) | 1999-03-20 |
| HUT60735A (en) | 1992-10-28 |
| ES2060303T3 (es) | 1994-11-16 |
| CA2042336A1 (en) | 1991-11-12 |
| EP0456519B1 (en) | 1994-07-13 |
| DE69102816D1 (de) | 1994-08-18 |
| HU215832B (hu) | 1999-04-28 |
| EP0456519A1 (en) | 1991-11-13 |
| KR910019988A (ko) | 1991-12-19 |
| PT97637B (pt) | 1998-08-31 |
| HK1005728A1 (en) | 1999-01-22 |
| CS138591A3 (en) | 1992-03-18 |
| CZ284343B6 (cs) | 1998-10-14 |
| HU911568D0 (en) | 1991-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0456519T3 (da) | Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse | |
| CS556587A2 (en) | Process for preparing aminoderivatives | |
| NO179246C (no) | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav | |
| DK359289D0 (da) | 4-oxoquinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| DK0637586T3 (da) | 2-(Piperidin-4-yl, pyridin-4-yl og tetrahydropyridin-4-yl)-benzofuran-7-carbamatderivater, deres fremstilling og anvendelse | |
| DK26289A (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
| ZA88686B (en) | Cinnoline-carboxamides and process for their preparation | |
| DK0471297T3 (da) | 3-(1,2-Benzisoxazol-3-yl)-4-pyridinaminer og derivater | |
| DK0499231T3 (da) | 9-Aminotetrahydroacridiner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| ZA917141B (en) | 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments | |
| RU93004471A (ru) | Пиперидилокси- и хинуклидинилокси-изоксазоловые производные и фармацевтическая композиция на их основе | |
| NO905128L (no) | Fremgangsmaate og mellomprodukter for fremstilling og anvendelse av heksahydro-1h-quino(4,3,2-ef)(1,4)benzoksazepiner samt beslektede forbindelser. |